Developing new contraceptive methods for women, especially those who are obese.
CCTN-CONTRACEPTIVE DEVELOPMENT PROGRAM – CORE FUNCTION ACTIVITIES FOR SITES OF FEMALE CONTRACEPTIVE STUDIES - UPENN
This study is looking to develop new birth control options that help prevent unplanned pregnancies while keeping women, especially those who are obese, safe from blood clots, and it's designed for women who want effective and safe contraceptive choices.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pennsylvania NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-11144231 on NIH RePORTER |
What this research studies
This research focuses on creating new contraceptive methods that effectively prevent unintended pregnancies while also minimizing the risk of venous thromboembolism (VTE), particularly in obese women. The Contraceptive Clinical Trials Network (CCTN) will develop and implement clinical trial protocols aimed at evaluating these new contraceptive agents. By conducting these trials, the research aims to ensure that the contraceptives are both safe and effective for a diverse population of women.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include women seeking effective contraception, especially those who are obese or have medical conditions that make current contraceptive options unsuitable.
Not a fit: Patients who are not seeking contraception or who do not have any medical conditions that contraindicate current contraceptive methods may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to safer and more effective contraceptive options for women, particularly those at higher risk due to obesity.
How similar studies have performed: Previous research has shown promise in developing new contraceptive methods, but this specific approach targeting obese women is relatively novel.
Where this research is happening
Philadelphia, United States
- University of Pennsylvania — Philadelphia, United States (Active)
Researchers
- Principal investigator: Schreiber, Courtney — University of Pennsylvania
- Study coordinator: Schreiber, Courtney
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.